• Login
    View Item 
    •   Home
    • Centers & Institutes
    • Comprehensive Sickle Cell Center
    • Comprehensive Sickle Cell Center: Faculty Research and Presentations
    • View Item
    •   Home
    • Centers & Institutes
    • Comprehensive Sickle Cell Center
    • Comprehensive Sickle Cell Center: Faculty Research and Presentations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Scholarly CommonsCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    About

    AboutCreative CommonsAugusta University LibrariesUSG Copyright Policy

    Statistics

    Display statistics

    Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    1471-2350-4-6.pdf
    Size:
    294.5Kb
    Format:
    PDF
    Download
    Authors
    Adams, Gaye T
    Snieder, Harold
    McKie, Virgil C
    Clair, Betsy
    Brambilla, Donald
    Adams, Robert J
    Kutlar, Ferdane
    Kutlar, Abdullah
    Issue Date
    2004-05-10
    URI
    http://hdl.handle.net/10675.2/36
    
    Metadata
    Show full item record
    Abstract
    BACKGROUND: The phenotypic heterogeneity of sickle cell disease is likely the result of multiple genetic factors and their interaction with the sickle mutation. High transcranial doppler (TCD) velocities define a subgroup of children with sickle cell disease who are at increased risk for developing ischemic stroke. The genetic factors leading to the development of a high TCD velocity (i.e. cerebrovascular disease) and ultimately to stroke are not well characterized. METHODS: We have designed a case-control association study to elucidate the role of genetic polymorphisms as risk factors for cerebrovascular disease as measured by a high TCD velocity in children with sickle cell disease. The study will consist of two parts: a candidate gene study and a genomewide screen and will be performed in 230 cases and 400 controls. Cases will include 130 patients (TCD > or = 200 cm/s) randomized in the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study as well as 100 other patients found to have high TCD in STOP II screening. Four hundred sickle cell disease patients with a normal TCD velocity (TCD < 170 cm/s) will be controls. The candidate gene study will involve the analysis of 28 genetic polymorphisms in 20 candidate genes. The polymorphisms include mutations in coagulation factor genes (Factor V, Prothrombin, Fibrinogen, Factor VII, Factor XIII, PAI-1), platelet activation/function (GpIIb/IIIa, GpIb IX-V, GpIa/IIa), vascular reactivity (ACE), endothelial cell function (MTHFR, thrombomodulin, VCAM-1, E-Selectin, L-Selectin, P-Selectin, ICAM-1), inflammation (TNFalpha), lipid metabolism (Apo A1, Apo E), and cell adhesion (VCAM-1, E-Selectin, L-Selectin, P-Selectin, ICAM-1). We will perform a genomewide screen of validated single nucleotide polymorphisms (SNPs) in pooled DNA samples from 230 cases and 400 controls to study the possible association of additional polymorphisms with the high-risk phenotype. High-throughput SNP genotyping will be performed through MALDI-TOF technology using Sequenom's MassARRAY system. DISCUSSION: It is expected that this study will yield important information on genetic risk factors for the cerebrovascular disease phenotype in sickle cell disease by clarifying the role of candidate genes in the development of high TCD. The genomewide screen for a large number of SNPs may uncover the association of novel polymorphisms with cerebrovascular disease and stroke in sickle cell disease.
    Citation
    BMC Med Genet. 2003 Jul 18; 4:6
    ae974a485f413a2113503eed53cd6c53
    10.1186/1471-2350-4-6
    Scopus Count
    Collections
    Comprehensive Sickle Cell Center: Faculty Research and Presentations

    entitlement

    Related articles

    • Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study.
    • Authors: Seibert JJ, Glasier CM, Kirby RS, Allison JW, James CA, Becton DL, Kinder DL, Cox KS, Flick EL, Lairry F, Jackson JF, Graves RA
    • Issue date: 1998 Mar
    • Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing.
    • Authors: Nichols FT, Jones AM, Adams RJ
    • Issue date: 2001 Oct
    • Big strokes in small persons.
    • Authors: Adams RJ
    • Issue date: 2007 Nov
    • Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?
    • Authors: Jones A, Granger S, Brambilla D, Gallagher D, Vichinsky E, Woods G, Berman B, Roach S, Nichols F, Adams RJ
    • Issue date: 2005 Jan
    • Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation.
    • Authors: Bulas DI, Jones A, Seibert JJ, Driscoll C, O'Donnell R, Adams RJ
    • Issue date: 2000 Nov
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.